{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:01:08Z","timestamp":1791396068560,"version":"4.3.3"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Endometriosis and ovarian cancer share invasive, inflammatory, and pro-survival mechanisms in which CXCR4 signaling may play an important role, yet phytochemical modulators of this receptor remain insufficiently characterized. This study addressed that gap by integrating receptor reconstruction, ligand-guided docking, pharmacokinetic and toxicity prediction, pharmacophore mapping, density functional theory, replicated membrane-embedded molecular dynamics, and MM\/GBSA analysis. A native human CXCR4 model was generated using SWISS-MODEL with 98.2% template coverage and 100% sequence identity, while the co-crystallized IT1t ligand defined the docking cavity. Eighteen phytochemicals were screened, and naringenin achieved the most favorable predicted docking score (\u22126.361 kcal\/mol), exceeding apigenin (\u22125.927 kcal\/mol) and IT1t (\u22125.155 kcal\/mol). Naringenin formed predicted interactions with Tyr116, Arg188, and Tyr255, showed acceptable drug-likeness, solubility, and gastrointestinal absorption, and displayed a wider HOMO\u2013LUMO gap than apigenin. Two independent 100 ns simulations of the CXCR4 complexes with naringenin, apigenin, and IT1t indicated comparatively consistent structural behavior for naringenin, supported by RMSD, SASA, radius of gyration, hydrogen-bond, PCA, FEL, and DCCM analyses. MM\/GBSA estimates were also more favorable for naringenin than apigenin across both replicas. Its predicted LD50 was 2000 mg\/kg (toxicity class 4), emphasizing that favorable receptor interactions do not establish safety and require experimental toxicological assessment during further preclinical development. Collectively, naringenin emerged as the most coherent in silico prioritized CXCR4-binding candidate. However, the absence of receptor-binding assays, functional validation, and in vivo confirmation remains a major limitation.<\/jats:p>","DOI":"10.1371\/journal.pone.0359833","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:36:35Z","timestamp":1791394595000},"page":"e0359833","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Computational identification of natural CXCR4-binding candidates relevant to endometriosis and ovarian cancer progression"],"prefix":"10.1371","volume":"21","author":[{"given":"Sinan","family":"Karage\u00e7ili","sequence":"first","affiliation":[{"name":"\u00d6zel Nev Hospital","place":["Sanliurfa, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Inan","sequence":"additional","affiliation":[{"name":"\u00d6zel Nev Hospital","place":["Sanliurfa, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1979-7166","authenticated-orcid":true,"given":"Nouman","family":"Ali","sequence":"additional","affiliation":[{"name":"Rashid Latif Khan University","place":["Lahore, Pakistan"],"department":["Department of Molecular Biosciences, Faculty of Physical and Biological Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"issue":"2","key":"pone.0359833.ref001","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.fertnstert.2011.05.087","article-title":"Incidence of endometriosis by study population and diagnostic method: the ENDO study","volume":"96","author":"GM Buck Louis","year":"2011","journal-title":"Fertil Steril"},{"issue":"1","key":"pone.0359833.ref002","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1525-1438.2006.00754.x","article-title":"Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan","volume":"17","author":"H Kobayashi","year":"2007","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"pone.0359833.ref003","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/biolre\/iox152","article-title":"Pharmacological blockage of the CXCR4-CXCL12 axis in endometriosis leads to contrasting effects in proliferation, migration, and invasion","volume":"98","author":"A Ruiz","year":"2018","journal-title":"Biol Reprod"},{"key":"pone.0359833.ref004","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3727\/096504015X14343704124430","article-title":"CXCL12-CXCR4 Axis Promotes Proliferation, Migration, Invasion, and Metastasis of Ovarian Cancer","volume":"22","author":"Q Guo","year":"2014","journal-title":"Oncol Res"},{"issue":"28","key":"pone.0359833.ref005","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1200\/JCO.2008.20.7209","article-title":"Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin\u2019s lymphoma","volume":"27","author":"JF DiPersio","year":"2009","journal-title":"J Clin Oncol"},{"issue":"6007","key":"pone.0359833.ref006","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.1194396","article-title":"Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists","volume":"330","author":"B Wu","year":"2010","journal-title":"Science"},{"issue":"4","key":"pone.0359833.ref007","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1002\/jcp.26054","article-title":"Apigenin induces ROS-dependent apoptosis and ER stress in human endometriosis cells","volume":"233","author":"S Park","year":"2018","journal-title":"J Cell Physiol"},{"issue":"12","key":"pone.0359833.ref008","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/molehr\/gax057","article-title":"Naringenin induces mitochondria-mediated apoptosis and endoplasmic reticulum stress by regulating MAPK and AKT signal transduction pathways in endometriosis cells","volume":"23","author":"S Park","year":"2017","journal-title":"Mol Hum Reprod"},{"key":"pone.0359833.ref009","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jnutbio.2019.05.003","article-title":"Naringenin ameliorates progression of endometriosis by modulating Nrf2\/Keap1\/HO1 axis and inducing apoptosis in rats","volume":"70","author":"R Kapoor","year":"2019","journal-title":"J Nutr Biochem"},{"issue":"2","key":"pone.0359833.ref010","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"O Trott","year":"2010","journal-title":"J Comput Chem"},{"issue":"6","key":"pone.0359833.ref011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0352451","article-title":"AI-driven molecular diversification and ligand-based optimization of macitentan derivatives targeting VEGFR1 and endothelin signaling pathways","volume":"21","author":"SK Sahin","year":"2026","journal-title":"PLoS One"},{"key":"pone.0359833.ref012","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-0716-1406-8_1","article-title":"The Protein Data Bank Archive","volume":"2305","author":"S Velankar","year":"2021","journal-title":"Methods Mol Biol"},{"key":"pone.0359833.ref013","doi-asserted-by":"crossref","DOI":"10.1002\/elps.200900140","article-title":"Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective","volume":"30","author":"N Guex","year":"2009","journal-title":"Electrophoresis"},{"issue":"4","key":"pone.0359833.ref014","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF00228148","article-title":"AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR","volume":"8","author":"RA Laskowski","year":"1996","journal-title":"J Biomol NMR"},{"issue":"9","key":"pone.0359833.ref015","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/pro.5560020916","article-title":"Verification of protein structures: patterns of nonbonded atomic interactions","volume":"2","author":"C Colovos","year":"1993","journal-title":"Protein Sci"},{"key":"pone.0359833.ref016","unstructured":"Jejurikar BL, Rohane SH. Drug designing in discovery studio. 2021."},{"key":"pone.0359833.ref017","article-title":"PubChem Substance and Compound databases","volume":"44","author":"S Kim","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pone.0359833.ref018","doi-asserted-by":"crossref","first-page":"24565","DOI":"10.1038\/s41598-024-82302-0","article-title":"In silico investigation of ketamine and methylphenidate drug-drug conjugate for MDD and ADHD treatment using MD simulations and MMGBSA","volume":"15","author":"B Asrar","year":"2025","journal-title":"Sci Rep"},{"issue":"4","key":"pone.0359833.ref019","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1021\/acs.jcim.4c02158","article-title":"OpenMMDL - Simplifying the Complex: Building, Simulating, and Analyzing Protein\u2013Ligand Systems in OpenMM","volume":"65","author":"V Talagayev","year":"2025","journal-title":"J Chem Inform Model"},{"key":"pone.0359833.ref020","unstructured":"Huey R, Morris GM, Forli S. Using AutoDock 4 and AutoDock vina with AutoDockTools: a tutorial. The Scripps Research Institute Molecular Graphics Laboratory. 2012. 1000 p."},{"issue":"1","key":"pone.0359833.ref021","doi-asserted-by":"crossref","first-page":"11848","DOI":"10.1038\/s41598-026-41232-9","article-title":"AI fragmentation-based optimization of Sorafenib derivatives targeting VEGFR2 for angiogenesis-related pathologies: a structure-based in-silico study","volume":"16","author":"D Inan","year":"2026","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0359833.ref022","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13321-019-0362-7","article-title":"DockRMSD: an open-source tool for atom mapping and RMSD calculation of symmetric molecules through graph isomorphism","volume":"11","author":"EW Bell","year":"2019","journal-title":"J Cheminform"},{"key":"pone.0359833.ref023","volume-title":"LigPlot+: multiple ligand\u2013protein interaction diagrams for drug discovery","author":"RA Laskowski","year":"2011"},{"issue":"2","key":"pone.0359833.ref024","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1298","article-title":"Using PyMOL as a platform for computational drug design","volume":"7","author":"S Yuan","year":"2017","journal-title":"WIREs Comput Mol Sci"},{"key":"pone.0359833.ref025","doi-asserted-by":"crossref","first-page":"108906","DOI":"10.1016\/j.compbiolchem.2026.108906","article-title":"AI-fragmented derivatives of methotrexate to design effective and safer DHFR inhibitor: A computational breakthrough for ectopic pregnancy therapy","volume":"122","author":"D Inan","year":"2026","journal-title":"Comput Biol Chem"},{"issue":"1","key":"pone.0359833.ref026","doi-asserted-by":"crossref","first-page":"13462","DOI":"10.1038\/s41598-026-42662-1","article-title":"Computational screening of AI-derived cyclotides as putative VEGFR2 binders for wound-site angiogenesis","volume":"16","author":"\u00d6 Karaca Ocak","year":"2026","journal-title":"Sci Rep"},{"key":"pone.0359833.ref027","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"A Daina","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"pone.0359833.ref028","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1142\/S2737416523500631","article-title":"Assessment of Melia azedarach plant extracts activity against hypothetical protein of mycobacterium tuberculosis via GC-MS analysis and in-silico approaches","volume":"23","author":"M Naveed","year":"2024","journal-title":"J Comput Biophys Chem"},{"key":"pone.0359833.ref029","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: a webserver for the prediction of toxicity of chemicals","volume":"52","author":"P Banerjee","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"pone.0359833.ref030","first-page":"1","article-title":"The Pharmit Backend: A Computer Systems Approach to Enabling Interactive Online Drug Discovery","volume":"62","author":"DR Koes","year":"2018","journal-title":"IBM J Res Dev"},{"issue":"1","key":"pone.0359833.ref031","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41598-024-51954-3","article-title":"The natural breakthrough: phytochemicals as potent therapeutic agents against spinocerebellar ataxia type 3","volume":"14","author":"M Naveed","year":"2024","journal-title":"Sci Rep"},{"key":"pone.0359833.ref032","doi-asserted-by":"crossref","first-page":"128715","DOI":"10.1016\/j.molstruc.2020.128715","article-title":"DFT studies on vibrational and electronic spectra, HOMO\u2013LUMO, MEP, HOMA, NBO and molecular docking analysis of benzyl-3-N-(2, 4, 5-trimethoxyphenylmethylene) hydrazinecarbodithioate","volume":"1220","author":"MA Mumit","year":"2020","journal-title":"J Mol Struct"},{"key":"pone.0359833.ref033","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkr703","article-title":"OPM database and PPM web server: resources for positioning of proteins in membranes","volume":"40","author":"MA Lomize","year":"2012","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pone.0359833.ref034","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","article-title":"CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM Simulations Using the CHARMM36 Additive Force Field","volume":"12","author":"J Lee","year":"2016","journal-title":"J Chem Theory Comput"},{"issue":"1","key":"pone.0359833.ref035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nmeth.4067","article-title":"CHARMM36m: an improved force field for folded and intrinsically disordered proteins","volume":"14","author":"J Huang","year":"2017","journal-title":"Nat Methods"},{"issue":"1","key":"pone.0359833.ref036","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bpj.2014.05.034","article-title":"CHARMM all-atom additive force field for sphingomyelin: elucidation of hydrogen bonding and of positive curvature","volume":"107","author":"RM Venable","year":"2014","journal-title":"Biophys J"},{"key":"pone.0359833.ref037","doi-asserted-by":"crossref","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B, et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1\u20132:19\u201325. doi: 10.1016\/j.softx.2015.06.001","DOI":"10.1016\/j.softx.2015.06.001"},{"key":"pone.0359833.ref038","doi-asserted-by":"crossref","unstructured":"Bussi G, Donadio D, Parrinello M. Canonical sampling through velocity rescaling. J Chem Phys. 2007;126(1):014101.","DOI":"10.1063\/1.2408420"},{"issue":"11","key":"pone.0359833.ref039","doi-asserted-by":"crossref","first-page":"114107","DOI":"10.1063\/5.0020514","article-title":"Pressure control using stochastic cell rescaling","volume":"153","author":"M Bernetti","year":"2020","journal-title":"J Chem Phys"},{"issue":"12","key":"pone.0359833.ref040","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: A linear constraint solver for molecular simulations","volume":"18","author":"B Hess","year":"1997","journal-title":"J Comput Chem"},{"issue":"10","key":"pone.0359833.ref041","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: A New Tool to Perform End-State Free Energy Calculations with GROMACS","volume":"17","author":"MS Vald\u00e9s-Tresanco","year":"2021","journal-title":"J Chem Theory Comput"},{"key":"pone.0359833.ref042","doi-asserted-by":"crossref","first-page":"426956","DOI":"10.1155\/2010\/426956","article-title":"Role of chemokine network in the development and progression of ovarian cancer: a potential novel pharmacological target","volume":"2010","author":"F Barbieri","year":"2010","journal-title":"J Oncol"},{"issue":"14","key":"pone.0359833.ref043","doi-asserted-by":"crossref","first-page":"7371","DOI":"10.3390\/ijms22147371","article-title":"CXCL12-CXCR4\/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies","volume":"22","author":"T Khare","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"12","key":"pone.0359833.ref044","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1593\/neo.111076","article-title":"Noninvasive imaging reveals inhibition of ovarian cancer by targeting CXCL12-CXCR4","volume":"13","author":"P Ray","year":"2011","journal-title":"Neoplasia"},{"issue":"2","key":"pone.0359833.ref045","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1158\/1535-7163.MCT-17-0643","article-title":"A Role for CXCR4 in Peritoneal and Hematogenous Ovarian Cancer Dissemination","volume":"17","author":"A Figueras","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"pone.0359833.ref046","doi-asserted-by":"crossref","first-page":"154401","DOI":"10.1016\/j.phymed.2022.154401","article-title":"Naringenin suppresses epithelial ovarian cancer by inhibiting proliferation and modulating gut microbiota","volume":"106","author":"C Lin","year":"2022","journal-title":"Phytomedicine"},{"issue":"1","key":"pone.0359833.ref047","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2006.02.036","article-title":"Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression","volume":"103","author":"Y-P Jiang","year":"2006","journal-title":"Gynecol Oncol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0359833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:36:45Z","timestamp":1791394605000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0359833"}},"subtitle":[],"editor":[{"given":"Chandrabose","family":"Selvaraj","sequence":"first","affiliation":[{"name":"AMET University","place":["INDIA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":47,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0359833","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]}}}